Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma

AIDS

Volumn 17, Issue 12, 2003, Pages 1787-1793

  Skiest, Daniel J ^a,b   Crosby, Craig ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

AIDS; HAART; Highly active antiretroviral therapy; HIV; Primary central nervous system lymphoma; Survival

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CALCULATION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN TISSUE; LYMPHOMA; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; TEACHING HOSPITAL; TREATMENT OUTCOME; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; CENTRAL NERVOUS SYSTEM NEOPLASMS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPHOMA, AIDS-RELATED; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; VIRAL LOAD;

EID: 0042732966     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200308150-00007     Document Type: Article

References (28)

1. Bower M, Fife K, Sullivan A, Kirk S, Phillips RH, Nelson M, et al. Treatment outcome in presumed and confirmed AIDS-related primary cerebral lymphoma. Eur J Cancer 1999, 35:601-604.
2. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993, 119:1093-1104.
3. Levy R, Bredesen D, Rosenblum M. Neurological manfestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature. J Neurosurg 1985, 62: 475-495.
4. McArthur J. Neurologic manifestations of AIDS. Medicine 1987, 66:407-437.
5. Hogg RS, Heath KV, Yip B, Craib KJ, O'Shaughnessy MV, Schechter MT, et al. Improved survival among HIV-infected individuals following initiation of antiretroviral therapy. JAMA 1998, 279:450-454.
6. Palella FJ Jr, Delaney KM, Moorman AC, LoveLess MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engt J Med 1998, 338:853-860.
7. Grulich AE. AIDS-associated non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr 1999, 21(Suppl 1 ):S27-S30.
8. Conti S, Masocco M, Pezzotti P, Toccaceli V, Vichi M, Boros S, et al. Differential impact of combined antiretroviral therapy on the survival of italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 2000, 25:451-458.
9. Ledergerber B, Telenti A, Egger M. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 1999, 319:23-24.
10. Gerard L, Galicier L, Maillard A, Boulanger E, Quint L, Matheron S, et al. Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival. J Acquir Immune Defic Syndr 2002, 30:478-484.
11. Inungu J, Melendez MF, Montgomery JP. AIDS-related primary brain lymphoma in Michigan, January 1990 to December 2000. AIDS Patient Care STDS 2002, 16:107-112.
12. Nuckols JD, Liu K, Burchette JL, McLendon RE, Traweek ST. Primary central nervous system lymphomas: a 30-year experience at a single institution. Mod Pathol 1999, 12:1167-1173.
13. Goldstein JD, Dickson DW, Moser FG, Hirschfeld AD, Freeman K, Llena JF, et al. Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation. Cancer 1991, 67:2756-2765.
14. Cote TR, Manns A, Hardy CR, Yellin FJ, Hartge P. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996, 88:675-679.
15. McGowan JP, Shah S. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 1998, 12:952-954.
16. Hoffmann C, Tabrizian S, Wolf E, Eggers C, Stoehr A, Plettenberg A, et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001, 15:2119-2127.
17. Chamberlain MC, Kormanik PA. AIDS-related central nervous system lymphomas. J Neurooncol 1999, 43:269-276.
18. So U, Beckstead J, Davis R. Primary central nervous system lymphoma in Acquired Immune Deficiency Syndrome: A clinical and pathological study. Ann Neurol 1986, 20:566-572.
19. Gill PS, Levine AM, Meyer PR, Boswell WD, Burkes RL, Parker JW, et al. Primary central nervous system lymphoma in homosexual men. Clinical, immunologic, and pathologic features. Am J Med 1985, 78:742-748.
20. Baumgartner JE, Rachlin JR, Beckstead JH, Meeker TC, Levy RM, Wara WM, et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990, 73:206-211.
21. Donahue BR, Sullivan JW, Cooper JS. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 1995, 76:328-332.
22. Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurol Sci 1999, 163:32-38.
23. Ciacci JD, Tellez C, von Roenn J, Levy RM. Lymphoma of the central nervous system in AIDS. Semin Neurol 1999, 19: 213-221.
24. Skiest DJ. Focal neurological disease in patients with acquired immunodeficiency syndrome. Clin Infect Dis 2002, 34:103-115.
25. Jacomet C, Girard PM, Lebrette MG, Farese VL, Monfort L, Rozenbaum W. Intravenous methotrexate for primary central nervous system non- Hodgkin's lymphoma in AIDS. AIDS 1997, 11:1725-1730.
26. Aboulafia DM. Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma. Clin Infect Dis 2002, 34:1660-1662.
27. Raez L, Cabral L, Cai JP, Landy H, Sfakianakis G, Byrne GE Jr, et al. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 1999, 15:713-719.
28. Slobod KS, Taylor GH, Sandlund JT, Furth P, Helton KJ, Sixbey JW. Epstein-Barr virus-targeted therapy for AIDS-related primary lymphoma of the central nervous system. Lancet 2000, 356:1493-1494.